Nsclc Adenocarcinoma Clinical Trials

ReadTheTrial indexes 2 studies for Nsclc Adenocarcinoma. The most common development stage is Phase 1 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Nsclc Adenocarcinoma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 2
100%

Trial Status Breakdown

Trials for Nsclc Adenocarcinoma

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors

NCT07277413 · RECRUITING · Phase 1

A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE892 as Monotherapy and Combination Therapy in Participants With MTAP-Deleted Advanced Solid Tumors

NCT07277413 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Nsclc Adenocarcinoma?

There are 2 clinical trials listed for Nsclc Adenocarcinoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Nsclc Adenocarcinoma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Nsclc Adenocarcinoma trials in?

Current Nsclc Adenocarcinoma trials are distributed across: Phase 1 (2).

Find More Trials